Regenerex Pharma appoints Kenneth Perry as CFO; Brent Wilson resigns effective March 31, 2025

REGENEREX PHARMA, INC.

Kenneth W. Perry appointed CFO effective March 31, 2025; 39 years of healthcare finance experience.
Brent Wilson resigned as CFO on March 31, 2025, citing personal reasons.
Perry holds an MBA in Finance from Mississippi State and a BS in Accounting from Tennessee Tech.
Previously served as Division CFO for HCA and founded Lasis Healthcare; multiple award-winning CFO.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Brent Wilson

Chief Financial Officer

RGPX · REGENEREX PHARMA, INC.

Effective: 2025-03-31
Successor: Kenneth W. Perry
Filed: April 2, 2025, 7:59 PM ET

Effective March 31, 2025, Mr. Brent Wilson resigned his position as Chief Financial Officer of the Company due to personal reasons.

Appointed

Kenneth W. Perry

Chief Financial Officer

RGPX · REGENEREX PHARMA, INC.

Effective: 2025-03-31
Filed: April 2, 2025, 7:59 PM ET

Effective March 31, 2025, Mr. Kenneth W. Perry has been appointed to serve as Chief Financial Officer for the company

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Brent Wilson resigned as Chief Financial Officer at REGENEREX PHARMA, INC..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

Effective March 31, 2025, Mr. Brent Wilson resigned his position as Chief Financial Officer of the Company due to personal reasons.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Kenneth W. Perry was appointed as Chief Financial Officer at REGENEREX PHARMA, INC..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

Effective March 31, 2025, Mr. Kenneth W. Perry has been appointed to serve as Chief Financial Officer for the company

View on SEC.gov

REGENEREX PHARMA, INC. filing history →

Source: SEC EDGAR

accession 0001472375-25-000037

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.